Marked prolongation of skin homograft survival with niridazole. A first report

Mandel, M.A.; Mahmoud, A.A.; Warren, K.S.

Plastic and Reconstructive Surgery 55(1): 76-89

1975


ISSN/ISBN: 0032-1052
PMID: 1089984
Document Number: 83882
Niridazole, a nitroheterocyclic drug used to treat helminth infections is reported for the first time to suppress cell-mediated immunity, as ascertained by multiple in vivo assays. Skin homograft survival time was significantly prolonged in mice, without loss of animals due to drug toxicity.

Document emailed within 1 workday
Secure & encrypted payments